Lakefront Biotherapeutics (LKFT) Consolidated Net Income (2014 - 2026)
Lakefront Biotherapeutics (LKFT) recorded Consolidated Net Income of $2.45 million in the quarter ended Jun 30, 2026, compared with -$119.64 million a year earlier and down 85.6% from the prior quarter.
Lakefront Biotherapeutics (LKFT) Consolidated Net Income (2014 - 2026) Analysis & Trends
On a TTM basis, Lakefront Biotherapeutics' Consolidated Net Income came in at $373.84 billion as of Jun 30, 2026; for the year ended Dec 31, 2025, it was $362.54 billion.
- Across earlier years, Consolidated Net Income came in at $80.18 million in the year ended Dec 31, 2024 (-64.8%), $227.77 million in the year ended Dec 31, 2023, -$229.75 million in the year ended Dec 31, 2022 and -$122.16 million in the year ended Dec 31, 2021.
- Quarterly Consolidated Net Income has ranged from -$236.34 million in the quarter ended Sep 30, 2025 to $374.06 billion in the quarter ended Dec 31, 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at $16.97 million (quarter ended Mar 31, 2026), $374.06 billion (quarter ended Dec 31, 2025) and -$236.34 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Lakefront Biotherapeutics | 1.94 Bn | 1.94 Bn | 3.51 Mn | 2.45 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.45 Mn |
| Mar 31, 2026 | 16.97 Mn |
| Dec 31, 2025 | 374.06 Bn |
| Sep 30, 2025 | -236.34 Mn |
| Jun 30, 2025 | -119.64 Mn |
| Mar 31, 2025 | -161.36 Mn |
| Dec 31, 2024 | 27.04 Mn |
| Sep 30, 2024 | -24.45 Mn |
| Jun 30, 2024 | -20.65 Mn |
| Mar 31, 2024 | 98.01 Mn |
| Dec 31, 2023 | 169.56 Mn |
| Sep 30, 2023 | 28.09 Mn |
| Jun 30, 2023 | 5.55 Mn |
| Mar 31, 2023 | 24.91 Mn |
| Dec 31, 2022 | -211.40 Mn |
| Sep 30, 2022 | 21.69 Mn |
| Jun 30, 2022 | -20.26 Mn |
| Mar 31, 2022 | -14.94 Mn |
| Dec 31, 2021 | 18.73 Mn |
| Sep 30, 2021 | -141.04 Mn |
Lakefront Biotherapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=LKFT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();